Evaluation of the protective effect of MGSO4 in Equation of the motion and lung inflammation following Amiodarone infusion in stroke
Phase 1
- Conditions
- Stroke.Stroke, not specified as haemorrhage or infarction
- Registration Number
- IRCT201701011165N16
- Lead Sponsor
- Tehran University of medical sciences (Vice Chancellor of research)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
_
stroke confirmed by CT scan; Consent form was signed by family member; The patient was undergo treatment with amiodarone; The patient had Atrial fibrilation
_Exclusion criteria:
Serum creatinin greater than 2 mg/dl; Hypermagnasemia occur in the patient; The patient do not receive treatment for more than 24 hours.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Infarct size. Timepoint: Before and after of intervention. Method of measurement: CT Scan.;Immunoglobulin G, Immunoglobulin A, S100B Protein, SNSE Protein. Timepoint: Before and after of intervention. Method of measurement: Elisa Kit.
- Secondary Outcome Measures
Name Time Method